Highly accomplished and results-oriented Senior Quality Assurance Representative with over 20 years of experience in pharmaceutical and animal health industries. Proven expertise in GxP compliance, quality oversight for R&D and manufacturing, and laboratory operations. Adept at fostering cross-functional partnerships, driving compliance initiatives, and ensuring product quality and safety from development through commercialization.
Overview
22
22
years of professional experience
1
1
Certification
Work History
Sr. Representative - Quality Assurance
Elanco Animal Health
Indianapolis, IN
01.2013 - Current
Provide comprehensive quality oversight for animal health development activities, supporting both site-specific and global projects.
Partner with business units to ensure compliance with Elanco's internal requirements and applicable regulatory authorities.
Cultivate strong collaborations with Elanco R&D teams, offering expert consultation on quality-related matters.
Proactively enhance compliance through the implementation and monitoring of Elanco Global Quality Standards, training programs, and compliance tools.
Manage deviation and change control processes for project and site activities, ensuring successful CAPA and change action implementation.
Participate in the creation and revision of Quality standards and support the rollout of quality processes across the site.
Assist with regulatory inspection preparations, ensuring site inspection readiness.
Deliver quality and compliance training to R&D personnel.
Plan and conduct GxP oversight activities, including GRP, GCP, and GLP study reviews/audits, site self-inspections, and qualification/oversight of third-party work.
Issue inspection reports and review/approve responses and corrective actions, demonstrating proficiency in GCP.
Execute release of investigational batches (drug substance/API, drug product, vaccines), seed and cell lines, and other development materials per Elanco R&D Quality System requirements.
Act as Computer Systems Quality Assurance (CSQA) representative for associated projects and site activities.
Microbiologist
Elanco Animal Health
Greenfield, IN
01.2011 - 01.2013
Collaborated with technology partners on the design and development of vaccines for companion and food animals.
Executed mammalian cell culture and cell banking activities critical for animal vaccine development.
Authored and implemented protocols for cell banking and conducted optimization studies for cell culture processes.
Developed study protocols and reports for proof-of-concept and challenge model studies to evaluate vaccine efficacy.
Monitored clinical studies, ensuring CRO personnel and facilities met qualification standards and study activities adhered to protocols.
Partnered with Elanco Regulatory and Quality Assurance to ensure compliance with 9 CFR regulations and Elanco policies during study execution.
Microbiologist
Volt Services Group at Elanco Animal Health
Greenfield, IN
01.2010 - 01.2011
Played a key role in establishing a new laboratory dedicated to animal vaccine development.
Managed lab supplies and equipment, ensuring operational readiness.
Coordinated the acquisition of essential equipment, including bioreactors for vaccine production and a lyophilizer for vaccine preparation.
Performed mammalian cell culture for animal vaccine development and drafted cell banking protocols.
Conducted cell culture optimization studies and performed virus titrations (TCID50 and hemagglutination assay) for animal virus quantification.
Designed and implemented a study protocol to identify optimal serum-free media for culturing adherent MDCK cells.
Coordinated the transfer of viral and bacterin seed and cell reagent stocks from Pfizer Animal Health post-acquisition.
R&D Scientist
Thermo Fisher Scientific
Indianapolis, IN
01.2004 - 01.2009
Designed experimental methods to advance in-vitro diagnostic immunoassays from proof-of-concept to 510k submission.
Formulated assay reagents and components, analyzed data, and documented/interpreted results.
Prepared comprehensive protocols, technical reports, and data summaries.
Improved assay performance by optimizing conjugate load on microparticles, resulting in reduced lot-to-lot variability and increased reagent stability.
Developed an immunoassay for monitoring immunosuppressive therapy in transplant patients, achieving FDA clearance for blood-level testing.
NGF-KSU HACCP For the Feed Industry; IGP Institute-Kansas State University; September 2017
FSPCA Preventive Controls for Animal Food; Food Safety Preventive Controls Alliance-Kansas State University; September 2017
Corporate Introduction to GMPs; Eli Lilly Corporate Learning Center; February 2014
Basic Veterinary Immunology and Principles of Vaccination-Veterinary Biologics Training Program; Institute for International Cooperation in Animal Biologics; College of Veterinary Medicine, Iowa State University, Ames, IA; May 2013
A New QMS Immunoassay for the Quantitative Determination of Everolimus in Whole Blood; Alex Shvets, Jared Boyd, Jeff Voors, Mary Cox and Lili Arabshahi. Presented at American Association for Clinical Chemistry (AACC) 2006 Conference in Chicago, Ill.
Adenoviral Vectors as Agents of Gene Transfer to Promote Neuronal Cell Growth, Senior Seminar at Purdue University, 1999
Quality Assurance and Quality Control Coordinator at Elite Pharmaceuticals, Inc.Quality Assurance and Quality Control Coordinator at Elite Pharmaceuticals, Inc.